| ARS2/MAGL signaling in glioblastoma stem cells promotes self-renewal and M2-like polarization of tumor-associated macrophages J Yin, SS Kim, E Choi, YT Oh, W Lin, TH Kim, JK Sa, JH Hong, SH Park, ... Nature Communications 11 (1), 2978, 2020 | 95 | 2020 |
| Interplay between TRAP1 and sirtuin-3 modulates mitochondrial respiration and oxidative stress to maintain stemness of glioma stem cells HK Park, JH Hong, YT Oh, SS Kim, J Yin, AJ Lee, YC Chae, JH Kim, ... Cancer research 79 (7), 1369-1382, 2019 | 90 | 2019 |
| Transcriptional regulatory networks of tumor-associated macrophages that drive malignancy in mesenchymal glioblastoma JK Sa, N Chang, HW Lee, HJ Cho, M Ceccarelli, L Cerulo, J Yin, SS Kim, ... Genome biology 21, 1-17, 2020 | 79 | 2020 |
| Transglutaminase 2 inhibition reverses mesenchymal transdifferentiation of glioma stem cells by regulating C/EBPβ signaling J Yin, YT Oh, JY Kim, SS Kim, E Choi, TH Kim, JH Hong, N Chang, ... Cancer research 77 (18), 4973-4984, 2017 | 79 | 2017 |
| Phosphoserine phosphatase promotes lung cancer progression through the dephosphorylation of IRS-1 and a noncanonical L-serine-independent pathway SM Park, EH Seo, DH Bae, SS Kim, J Kim, W Lin, KH Kim, JB Park, ... Molecules and cells 42 (8), 604-616, 2019 | 22 | 2019 |
| Modulation of Nogo receptor 1 expression orchestrates myelin-associated infiltration of glioblastoma JH Hong, S Kang, JK Sa, G Park, YT Oh, TH Kim, J Yin, SS Kim, ... Brain 144 (2), 636-654, 2021 | 17 | 2021 |
| Inhibition of BMP signaling overcomes acquired resistance to cetuximab in oral squamous cell carcinomas J Yin, JE Jung, SI Choi, SS Kim, YT Oh, TH Kim, E Choi, SJ Lee, H Kim, ... Cancer letters 414, 181-189, 2018 | 16 | 2018 |
| Macrophage migration inhibitory factor (MIF) inhibitor 4-IPP downregulates stemness phenotype and mesenchymal trans-differentiation after irradiation in glioblastoma multiforme SH Lee, HJ Kwon, S Park, CI Kim, H Ryu, SS Kim, JB Park, JT Kwon PLoS One 16 (9), e0257375, 2021 | 13 | 2021 |
| Tissue factor is a critical regulator of radiation therapy-induced glioblastoma remodeling HM Jeon, JY Kim, HJ Cho, WJ Lee, D Nguyen, SS Kim, YT Oh, HJ Kim, ... Cancer Cell 41 (8), 1480-1497. e9, 2023 | 9 | 2023 |
| Development of a miRNA-controlled dual-sensing system and its application for targeting miR-21 signaling in tumorigenesis Y Seo, SS Kim, N Kim, S Cho, JB Park, JH Kim Experimental & Molecular Medicine 52 (12), 1989-2004, 2020 | 7 | 2020 |
| IGFBP5 is an ROR1 ligand promoting glioblastoma invasion via ROR1/HER2-CREB signaling axis W Lin, R Niu, SM Park, Y Zou, SS Kim, X Xia, S Xing, Q Yang, X Sun, ... Nature Communications 14 (1), 1578, 2023 | 6 | 2023 |
| Analysis of electric cigarette liquid effect on mouse brain tumor growth through EGFR and ERK activation HJ Kwon, YT Oh, S Park, SS Kim, J Park, J Yin, JH Hong, CI Kim, H Ryu, ... Plos one 16 (9), e0256730, 2021 | 5 | 2021 |
| Cross-talk between PARN and EGFR–STAT3 Signaling Facilitates Self-Renewal and Proliferation of Glioblastoma Stem Cells J Yin, Y Seo, J Rhim, X Jin, TH Kim, SS Kim, JH Hong, HS Gwak, H Yoo, ... Cancer Research 83 (22), 3693-3709, 2023 | 4 | 2023 |
| Integrated proteogenomic characterization of glioblastoma evolution KH Kim, S Migliozzi, H Koo, JH Hong, SM Park, S Kim, HJ Kwon, S Ha, ... Cancer Cell, 2024 | 3 | 2024 |
| The regulatory roles of mitochondrial metabolism dynamics and mitochondria calcium uniporter (MCU) in bevacizumab resistance of GBM Y Kim, C Kwak, JB Park, DH Nam, HW Rhee, SS Kim Advanced Therapeutics 6 (7), 2300067, 2023 | 1 | 2023 |
| Suppression of Glioblastoma Stem Cell Potency and Tumor Growth via LRRK2 Inhibition S Park, KH Kim, YH Bae, YT Oh, H Shin, HJ Kwon, CI Kim, SS Kim, ... International Journal of Stem Cells, 2024 | | 2024 |
| Fam20C Kinase as a Key Regulator of Bevacizumab Resistance in Mesenchymal Glioblastoma CI Kim, S Kim, SM Park, SS Kim, HJ Kwon, W Lin, S Park, S Ha, KH Ha, ... Advanced Therapeutics 7 (2), 2300309, 2024 | | 2024 |
| Translational mRNA profiling analysis of pseudopalisading cells in bevacizumab resistance of GBM Y Kim, TH Kim, S Sreynet, YS Oh, DH Nam, JB Park, SS Kim Advanced Therapeutics 6 (11), 2300148, 2023 | | 2023 |
